CD68 and neoplasm: found that high levels of CD68+ (a pan-macrophage marker), CD206+ (mannose receptor C type 1), and CD163+ tumor-infiltrating macrophage subpopulations in the vital tumor core of patients with IDH1R132H-non-mutant glioblastoma (n=241) were associated with improved survival (187).